Clinical Study

Antibacterial-Coated Suture in Reducing Surgical Site Infection in Breast Surgery: A Prospective Study

Table 1

Patient, tumor, and surgical characteristics.

Group 1Group 2P
n = 92 (%)n = 98 (%)

Patient characteristics

Age med (min–max)55.5 (14–86)54.5 (23–87)0.6
Breast surgery history24 (26)26 (26)0.9
Radiotherapy history1 (1)2 (2)0.6
Medical history
 Diabetes mellitus10 (11)7 (7)0.4
 Tobacco use14 (15)20 (20)0.4
 High blood pressure28 (30)25 (25)0.4
BMI med (min–max)23.9 (16.4–42.2)24.8 (17.5–48)0.8
Corticosteroid therapy1 (1)1 (1)0.9
Immunodepression1 (1)1 (1)0.9

Surgery

Mastectomy26 (28)28 (28)0.9
Conservative surgery56 (61)64 (65)0.5
Revision lumpectomy3 (3)4 (4)0.7
Lymph node biopsy23 (25)36 (37)0.08
Axillary lymphadenectomy34 (37)33 (34)0.6
Wire localization27 (29)41 (42)0.07

Tumor characteristics

Bilateral7 (8)14 (14)0.14
Malignant tumor65 (76)72 (77)0.9
Tumor size med (min–max)20.8 (4–65)21 (1–70)0.8
Multifocality7 (8)14 (14)0.14
Number of axillary lymph nodes med (min–max)11 (4–23)10 (5–22)0.4

Neoadjuvant therapies

Neoadjuvant chemotherapy7 (11)5 (7)0.4

Group 1: traditional suture material.
Group 2: sutures coated with triclosan.